SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-145969
Filing Date
2013-04-08
Accepted
2013-04-08 16:16:59
Documents
10
Period of Report
2013-05-17
Effectiveness Date
2013-04-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d468403ddef14a.htm DEF 14A 734161
2 GRAPHIC g468403g05e59.jpg GRAPHIC 11311
3 GRAPHIC g468403g20s51.jpg GRAPHIC 11399
4 GRAPHIC g468403g86b38.jpg GRAPHIC 6075
5 GRAPHIC g468403pc_pg1anew2.jpg GRAPHIC 27214
6 GRAPHIC g468403pc_pg1bnew1.jpg GRAPHIC 38095
7 GRAPHIC g468403pc_pg1c.jpg GRAPHIC 4499
8 GRAPHIC g468403pc_pg1d.jpg GRAPHIC 16140
9 GRAPHIC g468403pc_pg1e.jpg GRAPHIC 38573
10 GRAPHIC g468403pc_pg2new.jpg GRAPHIC 6104
  Complete submission text file 0001193125-13-145969.txt   956233
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-32405 | Film No.: 13748586
SIC: 2836 Biological Products, (No Diagnostic Substances)